Zeng Yi, Xiaomin Ma, Qiulan Tong, Lei Ma, Yunfei Tan, Danni Liu, Chaoliang Tan, Junze Chen, Xudong Li
{"title":"A Library of Polyphenol-Amino Acid Condensates for High-Throughput Continuous Flow Production of Nanomedicines with Ultra-High Drug Loading","authors":"Zeng Yi, Xiaomin Ma, Qiulan Tong, Lei Ma, Yunfei Tan, Danni Liu, Chaoliang Tan, Junze Chen, Xudong Li","doi":"10.1002/adma.202417534","DOIUrl":null,"url":null,"abstract":"<p>Synthesizing high drug-loading nanomedicines remains a formidable challenge, and achieving universally applicable, continuous, large-scale engineered production of such nanomedicines presents even greater difficulties. This study presents a scalable library of polyphenol-amino acid condensates. By selecting amino acids, the library enables precise customization of key properties, such as carrier capacity, bioactivity, and other critical attributes, offering a versatile range of options for various application scenarios. Leveraging the properties of solvent-mediated disassembly and reassembly of condensates achieved an ultra-high drug loading of 86% for paclitaxel. For a range of poorly soluble molecules, the drug loading capacity exceeded 50%, indicating broad applicability. Furthermore, employing a continuous microfluidic device, the production rate can reach 5 mL min<sup>−1</sup> (36 g per day), with the nanoparticle size precisely tunable and a polydispersity index (PDI) below 0.2. The polyphenol-based carrier demonstrates efficient cellular uptake and, in three distinct animal models, has been shown to enhance the therapeutic efficacy of paclitaxel without significant side effects. This study presents a streamlined, efficient, and scalable approach using microfluidics to produce nanomedicines with ultra-high drug loading, offering a promising strategy for the nanoformulation of poorly soluble drugs.</p>","PeriodicalId":114,"journal":{"name":"Advanced Materials","volume":"37 15","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adma.202417534","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Materials","FirstCategoryId":"88","ListUrlMain":"https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202417534","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Synthesizing high drug-loading nanomedicines remains a formidable challenge, and achieving universally applicable, continuous, large-scale engineered production of such nanomedicines presents even greater difficulties. This study presents a scalable library of polyphenol-amino acid condensates. By selecting amino acids, the library enables precise customization of key properties, such as carrier capacity, bioactivity, and other critical attributes, offering a versatile range of options for various application scenarios. Leveraging the properties of solvent-mediated disassembly and reassembly of condensates achieved an ultra-high drug loading of 86% for paclitaxel. For a range of poorly soluble molecules, the drug loading capacity exceeded 50%, indicating broad applicability. Furthermore, employing a continuous microfluidic device, the production rate can reach 5 mL min−1 (36 g per day), with the nanoparticle size precisely tunable and a polydispersity index (PDI) below 0.2. The polyphenol-based carrier demonstrates efficient cellular uptake and, in three distinct animal models, has been shown to enhance the therapeutic efficacy of paclitaxel without significant side effects. This study presents a streamlined, efficient, and scalable approach using microfluidics to produce nanomedicines with ultra-high drug loading, offering a promising strategy for the nanoformulation of poorly soluble drugs.
合成高载药量的纳米药物仍然是一项艰巨的挑战,而实现普遍适用的、连续的、大规模的纳米药物工程生产则面临着更大的困难。本研究提出了一个可扩展的多酚-氨基酸凝聚物库。通过选择氨基酸,该库可以精确定制关键属性,如载体容量,生物活性和其他关键属性,为各种应用场景提供多种选择。利用溶剂介导的缩合物的拆解和重组特性,紫杉醇的载药量高达86%。对于一系列难溶性分子,载药量超过50%,适用性广。此外,采用连续微流控装置,生产速度可达到5 mL min - 1 (36 g /天),纳米颗粒尺寸可精确调节,多分散性指数(PDI)低于0.2。基于多酚的载体显示出有效的细胞摄取,并且在三种不同的动物模型中,已被证明可以增强紫杉醇的治疗效果而没有明显的副作用。本研究提出了一种精简、高效、可扩展的方法,利用微流体生产具有超高载药量的纳米药物,为难溶性药物的纳米配方提供了一种有前途的策略。
期刊介绍:
Advanced Materials, one of the world's most prestigious journals and the foundation of the Advanced portfolio, is the home of choice for best-in-class materials science for more than 30 years. Following this fast-growing and interdisciplinary field, we are considering and publishing the most important discoveries on any and all materials from materials scientists, chemists, physicists, engineers as well as health and life scientists and bringing you the latest results and trends in modern materials-related research every week.